MRONJ: prevention and therapy

A tétel rövid nézete
dc.contributor.advisorLevente, Lukacs
dc.contributor.authorKaky, Ali
dc.contributor.departmentDE--Fogorvostudományi Kar
dc.date.accessioned2024-04-29T09:23:08Z
dc.date.available2024-04-29T09:23:08Z
dc.date.created2024-03-01
dc.description.abstractIn summary, the usage of denosumab and bisphosphonates can cause osteonecrosis, which is now a recognized and clinically relevant disease. It mainly affects people who have received subcutaneous denosumab therapies or intravenous nitrogen-containing bisphosphonates and have underlying malignant diseases. The presence of necrotic bone exposed in the craniofacial region is the clinical characteristic that indicates the presence of the disease. In a large number of cases, it is frequently accompanied by signs of infection, including discomfort, soft tissue edema in the surrounding area, or the development of draining fistulas. Additional complications during the course of the disease could include the involvement of the maxillary sinus or the development of pathological fractures in the jaw.
dc.description.coursefogorvos
dc.description.courselangangol
dc.description.degreeegységes, osztatlan
dc.format.extent48
dc.identifier.urihttps://hdl.handle.net/2437/369403
dc.language.isoen
dc.rights.accessHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.
dc.subjectOsteonecrosis
dc.subjectbisphosphonate
dc.subjecttreatment of osteonecrosis
dc.subject.dspaceMedicine::Dentistry
dc.titleMRONJ: prevention and therapy
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
ALI KAKY_THESIS2_2024.pdf
Méret:
6.47 MB
Formátum:
Adobe Portable Document Format
Leírás:
Megjelenítés
Engedélyek köteg
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
license.txt
Méret:
1.94 KB
Formátum:
Item-specific license agreed upon to submission
Leírás:
Letöltés
Gyűjtemények
Theses (Faculty of Dentistry)